Researchers consulting recent reviews (PMID 41966639) should attend to the regulatory framing as much as the mechanism framing
The effectiveness of treatment will be analysed by examining the therapeutic success achieved in each arm at 8, 26 and 52 weeks, determining the 95% confidence interval for the percentage of patients in each treatment arm whose serum vitamin B12 concentrations become normalised
Sosne, G., Qiu, P., & Kurpakus-Wheater, M
It is not FDA-approved for the treatment, prevention, or cure of any disease
Morning injection is not recommended
Some patients still benefit from B12 shots and benefits like steadier energy across the day, especially if intake has dropped alongside appetite